Association between the infection probability of COVID-19 and ventilation rates: An update for SARS-CoV-2 variants

被引:0
|
作者
Hui Dai
Bin Zhao
机构
[1] Tsinghua University,Department of Building Science, School of Architecture
[2] Tsinghua University,Beijing Key Laboratory of Indoor Air Quality Evaluation and Control
来源
Building Simulation | 2023年 / 16卷
关键词
COVID-19; SARS-CoV-2 variants; mask; ventilation; air purifier;
D O I
暂无
中图分类号
学科分类号
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the current coronavirus disease 2019 (COVID-19) pandemic, is evolving. Thus, the risk of airborne transmission in confined spaces may be higher, and corresponding precautions should be re-appraised. Here, we obtained the quantum generation rate (q) value of three SARS-CoV-2 variants (Alpha, Delta, and Omicron) for the Wells-Riley equation with a reproductive number-based fitted approach and estimated the association between the infection probability and ventilation rates. The q value was 89–165 h−1 for Alpha variant, 312–935 h−1 for Delta variant, and 725–2,345 h−1 for Omicron variant. The ventilation rates increased to ensure an infection probability of less than 1%, and were 8,000–14,000 m3 h−1, 26,000–80,000 m3 h−1, and 64,000–250,000 m3 h−1 per infector for the Alpha, Delta, and Omicron variants, respectively. If the infector and susceptible person wore N95 masks, the required ventilation rates decreased to about 1/100 of the values required without masks, which can be achieved in most typical scenarios. An air purifier was ineffective for reducing transmission when used in scenarios without masks. Preventing prolonged exposure time in confined spaces remains critical in reducing the risk of airborne transmission for highly contagious SARS-CoV-2 variants.
引用
收藏
页码:3 / 12
页数:9
相关论文
共 50 条
  • [41] COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants
    Stefanelli, Paola
    Rezza, Giovanni
    VACCINES, 2022, 10 (06)
  • [42] The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
    McLean, Gary
    Kamil, Jeremy
    Lee, Benhur
    Moore, Penny
    Schulz, Thomas F.
    Muik, Alexander
    Sahin, Ugur
    Tureci, Ozlem
    Pather, Shanti
    MBIO, 2022, 13 (02):
  • [43] Association of Lupus Anticoagulant status with Disease Course in SARS-CoV-2 (COVID-19) Infection
    Woo, Suhyeon
    Kim, Bohyun
    Heo, Nam Hun
    Kim, Min-sun
    Yoon, Young Ahn
    Choi, Young-Jin
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [44] Association of Lupus Anticoagulant status with Disease Course in SARS-CoV-2 (COVID-19) Infection
    Woo, Suhyeon
    Kim, Bohyun
    Heo, Nam Hun
    Kim, Min-Sun
    Yoon, Young Ahn
    Choi, Young-Jin
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [45] Recipients of COVID-19 vaccines face challenges of SARS-CoV-2 variants
    Li, Tianhong
    Luo, Kathy Qian
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (11): : 4642 - 4647
  • [46] Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19
    Ramos, A. M.
    Vela-Perez, M.
    Ferrandez, M. R.
    Kubik, A. B.
    Ivorra, B.
    COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION, 2021, 102
  • [47] SARS-CoV-2 and COVID-19 for the ophthalmologist
    Brandao-de-Resende, Camilo
    Diniz-Filho, Alberto
    de Almeida Brito, Fabiano
    Vasconcelos-Santos, Daniel Vitor
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 49 (01) : 70 - 80
  • [48] Pharmacological options in treating SARS-CoV-2 infection/COVID-19
    Fabian Akos
    Laszlo Istvan
    Juhasz Marianna
    Berhes Mariann
    Vegh Tamas
    Koszta Gyorgy
    Molnar Csilla
    Fulesdi Bela
    ORVOSI HETILAP, 2020, 161 (17) : 685 - 688
  • [49] SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
    Costela-Ruiz, Victor J.
    Illescas-Montes, Rebeca
    Puerta-Puerta, Jose M.
    Ruiz, Concepcion
    Melguizo-Rodriguez, Lucia
    CYTOKINE & GROWTH FACTOR REVIEWS, 2020, 54 : 62 - 75
  • [50] Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease Running title: Propolis against SARS-CoV-2 infection and COVID-19
    Berretta, Andresa Aparecida
    Duarte Silveira, Marcelo Augusto
    Capcha, Jose Manuel Condor
    De Jong, David
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 131